StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) shareholders

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$256.35−5.86 (-2.23%)

Close on Nov 17, 2026Market cap $28.20BP/E 25.6Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
95.4%
105M of 110M shares
Institutional holders
1,105
118 new, 70 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 42 sales
Net sold $48.85M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.9,308,8158.40%13G (passive) amendmentMar 31, 2025
Vanguard Capital Management8,274,5677.53%13G (passive)Mar 31, 2026
Vanguard Portfolio Management6,096,6295.54%13G (passive)Mar 31, 2026
State Street Corporation5,563,4215.00%13G (passive)Sep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of DGXValueChange% of portfolio
BlackRock, Inc.9,275,4118.43%$1.97B+103,1190.03%
Vanguard Capital Management LLC7,233,3946.57%$1.53B+87,7220.03%
Vanguard Portfolio Management LLC6,131,0455.57%$1.30B+49,6450.06%
State Street Corp5,516,6435.01%$1.17B+135,8220.03%
Price T Rowe Associates Inc /Md/5,444,9864.95%$1.15B−853,0010.12%
Boston Partners4,744,4734.31%$1.00B+732,2410.89%
JPMorgan Chase & Co3,520,4383.20%$748.59M−326,0180.04%
Geode Capital Management, LLC3,137,8732.85%$662.58M+51,5650.04%
Morgan Stanley2,460,4972.24%$521.50M−19,2230.03%
EdgePoint Investment Group Inc.2,247,5682.04%$476.37M+3,6993.60%
Dimensional Fund Advisors LP1,988,0481.81%$421.38M+38,5130.08%
Bank Of America Corp /De/1,935,1331.76%$410.15M+182,2310.03%
Grantham, Mayo, Van Otterloo & Co. LLC1,888,2071.72%$400.21M+5,1830.90%
Wells Fargo & Company/Mn1,751,2201.59%$371.17M−11,5490.06%
Davis Selected Advisers1,555,6121.41%$329.78M−62,2011.42%
Victory Capital Management Inc1,550,5561.41%$328.64M−295,7800.18%
Norges Bank1,406,6201.28%$298.13MNew0.03%
FMR LLC1,398,7351.27%$296.46M+456,5170.01%
Invesco Ltd.1,379,1151.25%$292.30M−259,3720.02%
Northern Trust Corp1,127,4541.02%$238.96M+13,2350.03%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20261,105105M95.4%118 / 430352 / 708M5M
Q1 20261,069103M93.3%123 / 350384 / 8919M8M
Q4 20251,050107M96.8%149 / 349347 / 9010M13M
Q3 20251,006109M99.3%115 / 359342 / 8210M9M
Q2 2025991108M98.5%121 / 365328 / 8313M7M
Q1 2025968103M94.1%145 / 315338 / 6111M6M
Q4 202489699M90.4%124 / 310304 / 598M7M
Q3 2024848100M90.7%94 / 294308 / 7319M8M
Q2 202483899M90.0%90 / 277300 / 597M13M
Q1 2024817105M95.3%90 / 269311 / 8912M8M
Q4 2023827101M92.2%108 / 254329 / 6410M6M
Q3 202379599M89.6%70 / 230337 / 827M7M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

761 funds held DGX in Q2 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of DGXValue% of fundAs of
Vanguard Total Stock Market Index Fund3,514,5263.19%$744.90M0.03%Jun 30, 2026
Vanguard 500 Index Fund2,868,3172.61%$607.94M0.04%Jun 30, 2026
Vanguard Mid-Cap Index Fund2,398,5882.18%$508.38M0.23%Jun 30, 2026
iShares Core S&P 500 ETF1,519,1091.38%$321.98M0.04%Jun 30, 2026
Fidelity 500 Index Fund1,407,6761.28%$274.36M0.03%May 31, 2026
Disciplined Value Mid Cap Fund1,222,7121.11%$259.15M1.12%Jun 30, 2026
JPMorgan Equity Income Fund1,153,0901.05%$244.40M0.56%Jun 30, 2026
T. Rowe Price Dividend Growth Fund, Inc.1,109,2421.01%$235.10M0.99%Jun 30, 2026
Disciplined Value Fund1,064,9820.97%$225.72M1.15%Jun 30, 2026
Victory Sycamore Established Value Fund1,055,0000.96%$223.61M1.45%Jun 30, 2026
Vanguard Value Index Fund1,052,6760.96%$223.11M0.09%Jun 30, 2026
Invesco S&P 500 Equal Weight ETF915,1930.83%$213.25M0.22%Jul 31, 2026
JPMorgan Mid Cap Value Fund787,2360.72%$166.85M1.49%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF781,9990.71%$165.74M0.41%Jun 30, 2026
T. Rowe Price U.S. Large-Cap Core Fund, Inc.781,3140.71%$165.60M0.92%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
J. E. DavisCEO and President, Director122,4230.11%Sep 3, 2026
Michael J. DeppeSVP, Corp. Controller & CAO35,9160.03%Nov 16, 2026
Patrick PlewmanSVP for Diagnostic Services14,6840.01%Nov 12, 2026
Subu RamachandranSVP, Regional Businesses2,8320.00%Nov 5, 2026
Mark E. DelaneySVP & Chief Commercial Officer12,9750.01%Nov 5, 2026
Catherine T. DohertyExecutive Vice President76,5010.07%Nov 5, 2026
Sam SamadExecutive Vice President & CFO33,5680.03%Oct 23, 2026
Karthik KuppusamySVP, Clinical Solutions15,6740.01%Oct 23, 2026
Michael E. PrevoznikSVP & General Counsel66,0140.06%Aug 31, 2026
Gary M. PfeifferDirector29,8020.03%Oct 28, 2026
Robert B. CarterDirector3,8740.00%Oct 23, 2026
Timothy L. MainDirector27,4780.02%Oct 23, 2026
Wright Lassiter IIIDirector10,3290.01%Oct 23, 2026
Vicky B. GreggDirector18,4490.02%Oct 23, 2026
Timothy C. WentworthDirector1,3580.00%Oct 2, 2026
Timothy M. RingDirector31,1400.03%May 21, 2026
Luis DiazDirector5,1960.00%May 21, 2026
Tracey DoiDirector7,7480.01%May 21, 2026
Denise M. MorrisonDirector11,9290.01%May 21, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Michael J. Deppe
SVP, Corp. Controller & CAO
Nov 13, 2026Sale(10b5-1 plan)−5,515$260.17$1.43M35,203
Michael J. Deppe
SVP, Corp. Controller & CAO
Nov 13, 2026Option exercise+5,515$103.57$571.19K40,718
Michael J. Deppe
SVP, Corp. Controller & CAO
Nov 13, 2026Sale(10b5-1 plan)−6,261$260.17$1.63M35,203
Michael J. Deppe
SVP, Corp. Controller & CAO
Nov 13, 2026Option exercise+6,261$95.80$599.77K41,464
Patrick Plewman
SVP for Diagnostic Services
Nov 9, 2026Sale(10b5-1 plan)−650$257.34$167.27K14,684
Patrick Plewman
SVP for Diagnostic Services
Nov 9, 2026Sale(10b5-1 plan)−6,793$257.34$1.75M15,334
Patrick Plewman
SVP for Diagnostic Services
Nov 9, 2026Option exercise+6,793$127.81$868.18K22,127
Patrick Plewman
SVP for Diagnostic Services
Nov 9, 2026Sale(10b5-1 plan)−4,274$257.34$1.10M15,334
Patrick Plewman
SVP for Diagnostic Services
Nov 9, 2026Option exercise+4,274$127.72$545.90K19,608
Subu Ramachandran
SVP, Regional Businesses
Nov 3, 2026Award+352––2,832
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Sale(10b5-1 plan)−2,907$251.24$730.35K71,949
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Sale(10b5-1 plan)−2,877$250.49$720.65K74,856
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Sale(10b5-1 plan)−3,004$249.40$749.21K77,733
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Sale(10b5-1 plan)−2,358$248.38$585.69K80,737
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Sale(10b5-1 plan)−1,151$246.98$284.28K83,095
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Sale(10b5-1 plan)−5,990$246.26$1.48M84,246
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Sale(10b5-1 plan)−3,818$245.45$937.14K90,236
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Option exercise+22,105$121.81$2.69M94,054
Catherine T. Doherty
Executive Vice President
Nov 3, 2026Award+4,827––71,949
Mark E. Delaney
SVP & Chief Commercial Officer
Nov 3, 2026Award+2,615––12,975
Gary M. Pfeiffer
Director
Oct 26, 2026Sale(10b5-1 plan)−1,203$243.00$292.33K29,802
Robert B. Carter
Director
Oct 21, 2026Small purchase+10$235.93$2.36K3,874
Sam Samad
Executive Vice President & CFO
Oct 21, 2026Award+90$235.94$21.23K33,568
Vicky B. Gregg
Director
Oct 21, 2026Award+63$235.94$14.86K18,449
Karthik Kuppusamy
SVP, Clinical Solutions
Oct 21, 2026Small purchase+33$235.94$7.79K13,619
Wright Lassiter III
Director
Oct 21, 2026Small purchase+6$235.96$1.42K10,329
Patrick Plewman
SVP for Diagnostic Services
Oct 21, 2026Small purchase+41$235.94$9.67K15,334
Timothy L. Main
Director
Oct 21, 2026Small purchase+18$235.94$4.25K22,478
Mark E. Delaney
SVP & Chief Commercial Officer
Oct 21, 2026Small purchase+25$235.94$5.90K10,360
J. E. Davis
CEO and President, Director
Sep 1, 2026Sale(10b5-1 plan)−10,000$242.72$2.43M122,423
Michael E. Prevoznik
SVP & General Counsel
Aug 28, 2026Option exercise+22,677$112.17$2.54M60,234
Michael E. Prevoznik
SVP & General Counsel
Aug 28, 2026Sale(10b5-1 plan)−16,010$242.88$3.89M44,224
Michael E. Prevoznik
SVP & General Counsel
Aug 28, 2026Sale(10b5-1 plan)−6,237$243.63$1.52M37,987
Michael E. Prevoznik
SVP & General Counsel
Aug 28, 2026Sale(10b5-1 plan)−430$244.51$105.14K37,557
Michael E. Prevoznik
SVP & General Counsel
Aug 28, 2026Gift−1,000––36,557
Mark E. Delaney
SVP & Chief Commercial Officer
Jul 28, 2026Sale(10b5-1 plan)−1,600$235.18$376.29K10,335
Vicky B. Gregg
Director
Jul 22, 2026Award+72$206.81$14.89K18,386
Robert B. Carter
Director
Jul 22, 2026Small purchase+11$206.80$2.27K3,864
Patrick Plewman
SVP for Diagnostic Services
Jul 22, 2026Small purchase+46$206.81$9.51K15,293
Karthik Kuppusamy
SVP, Clinical Solutions
Jul 22, 2026Small purchase+37$206.81$7.65K13,557
Wright Lassiter III
Director
Jul 22, 2026Small purchase+6$206.81$1.24K10,323
Mark E. Delaney
SVP & Chief Commercial Officer
Jul 22, 2026Small purchase+34$206.81$7.03K11,935
Sam Samad
Executive Vice President & CFO
Jul 22, 2026Award+102$206.81$21.09K33,478
Timothy L. Main
Director
Jul 22, 2026Small purchase+21$206.81$4.34K22,460
Karthik Kuppusamy
SVP, Clinical Solutions
Jun 4, 2026Sale(10b5-1 plan)−8,147$200.00$1.63M13,510
Karthik Kuppusamy
SVP, Clinical Solutions
Jun 4, 2026Option exercise+3,320$127.73$424.06K16,830
Karthik Kuppusamy
SVP, Clinical Solutions
Jun 4, 2026Option exercise+4,827$121.81$587.98K21,657
J. E. Davis
CEO and President, Director
Jun 1, 2026Sale(10b5-1 plan)−10,000$194.14$1.94M132,423
Vicky B. Gregg
Director
May 20, 2026Award+1,142––18,314
Timothy L. Main
Director
May 20, 2026Award+1,142––27,439
Tracey Doi
Director
May 20, 2026Award+1,142––7,748
Gary M. Pfeiffer
Director
May 20, 2026Award+1,142––31,005
Robert B. Carter
Director
May 20, 2026Award+1,142––3,853
Timothy C. Wentworth
Director
May 20, 2026Award+1,142––1,358
Wright Lassiter III
Director
May 20, 2026Award+1,142––10,317
Timothy M. Ring
Director
May 20, 2026Award+1,142––31,140
Luis Diaz
Director
May 20, 2026Award+1,142––5,196
Denise M. Morrison
Director
May 20, 2026Award+1,142––11,929
Patrick Plewman
SVP for Diagnostic Services
Apr 20, 2026Small purchase+49$194.70$9.54K15,247
Robert B. Carter
Director
Apr 20, 2026Small purchase+7$194.70$1.36K2,711

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.41%
4M shares short
Days to cover
3.6
At 1M shares a day
Change since last report
+4.5%
From 4M shares
Short volume, 20 days
67.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Quest Diagnostics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,712 shares on Oct 5, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Patrick Plewman
Officer
Nov 9, 202611,717$3.02MNov 9, 2026Restricted Stock Vesting
Catherine T. Doherty
Officer
Nov 3, 202622,105$5.58MNov 3, 2026Stock Option Exercise
Gary M. Pfeiffer
Director
Oct 26, 20261,203$292.33KOct 26, 2026Restricted Stock Vesting
J. E. Davis
Officer, Director
Sep 1, 202610,000$2.43MSep 1, 2026Restricted Stock Vesting
Michael E. Prevoznik
Officer
Aug 28, 202622,677$5.51MAug 28, 2026Stock Option Exercise
Mark E. Delaney
Officer
Jul 28, 20261,600$376.29KJul 28, 2026Restricted Stock Vesting
Karthik Kuppusamy
Officer
Jun 4, 20268,147$1.63MJun 4, 2026Stock Option Exercise
J. E. Davis
Officer, Director
Jun 1, 202610,000$1.94MJun 1, 2026Restricted Stock Vesting
Patrick Plewman
Officer
Mar 5, 20262,855$588.73KMar 5, 2026Restricted Stock Vesting
Catherine T. Doherty
Officer
Mar 5, 20265,558$1.15MMar 5, 2026Restricted Stock Vesting
Michael E. Prevoznik
Officer
Mar 5, 20263,878$799.68KMar 5, 2026Restricted Stock Vesting
Michael E. Prevoznik
Officer
Mar 3, 2026526$109.27KMar 3, 2026Restricted Stock Vesting
Catherine T. Doherty
Officer
Mar 3, 2026632$131.29KMar 3, 2026Restricted Stock Vesting
Patrick Plewman
Officer
Mar 3, 2026410$85.17KMar 3, 2026Restricted Stock Vesting
J. E. Davis
Officer, Director
Mar 2, 202610,000$2.13MMar 2, 2026Restricted Stock Vesting

Congress trades

18 trades in Quest Diagnostics reported by 8 members of the House

MemberTypeTradedAmountFiled
Julie Johnson
TX32 · joint account
SoldNov 3, 2025$1K–15KDec 11, 2025
Julie Johnson
TX32 · joint account
BoughtOct 30, 2025$1K–15KAug 5, 2026
279 days late
Julie Johnson
TX32 · joint account
SoldOct 30, 2025$1K–15KAug 5, 2026
279 days late
Julia Letlow
LA05
SoldJul 24, 2025$1K–15KJan 13, 2026
173 days late
Julia Letlow
LA05
BoughtApr 28, 2025$1K–15KJan 13, 2026
260 days late
Carol Devine Miller
WV01
SoldMar 10, 2025$15K–50KAug 13, 2026
521 days late
Carol Devine Miller
WV01
SoldMar 10, 2025$1K–15KApr 11, 2025
Earl Blumenauer
OR03 · spouse
SoldApr 4, 2024$1K–15KMay 4, 2024
Carol Devine Miller
WV01
BoughtNov 14, 2022$1K–15KDec 13, 2022
Kathy Manning
NC06 · joint account
SoldAug 3, 2022$1K–15KSep 14, 2022
Kathy Manning
NC06 · joint account
BoughtJul 20, 2022$1K–15KAug 10, 2022
Carol Devine Miller
WV01 · spouse
BoughtJul 28, 2021$15K–50KSep 2, 2022
401 days late
K. Michael Conaway
TX11 · spouse
SoldSep 12, 2016$1K–15KOct 12, 2016
Lois Frankel
FL22
SoldJun 20, 2016$1K–15KAug 16, 2016
57 days late
Lois Frankel
FL22
SoldMay 27, 2015$1K–15KJun 19, 2015
Richard L. Hanna
NY22 · joint account
SoldOct 15, 2014$1K–15KNov 11, 2014
Richard L. Hanna
NY22
SoldDec 30, 2013$1K–15KJan 15, 2014
Richard L. Hanna
NY22
SoldDec 27, 2013$100K–250KJan 15, 2014

See a number that looks wrong?